IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that Amgen (NASDAQ:AMGN) has announced an equity investment of £50 million into portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore” or “the Company”). The investment will be effected through the purchase of £50 million of existing ordinary […]
Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service Cambridge, United Kingdom – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic Medicine Service. Genomics England […]
SAN DIEGO — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, and Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and act on […]
Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology Daresbury, UK: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis’ advanced nucleic acid sample preparation chemistry in the […]
CE IVD Mark brings NGS-based clinical test for solid tumors to Europe CARLSBAD, Calif. — Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumors. Thermo Fisher will highlight the test during the European Society for […]
Five new genomics startups focused on therapeutics, diagnostics and informatics Illumina Accelerator welcomes five new startups to its eighth investment cycle. The genomics-based company creation engine focuses on building early-stage genomics companies and helps startups validate and create next-generation sequencing applications and bring those products to market. During the six-month cycle, Illumina Accelerator offers the […]
MOUNTAIN VIEW, Calif.–DNAnexus Inc. announced today it has been granted an Authority to Operate (ATO) under the Federal Risk and Authorization Management Program (FedRAMP) for the management and analysis of biomedical data on its cloud-based platform. This authorization enables Federal agencies to rapidly and securely integrate cloud-based biomedical informatics into their research and services, in compliance […]
Dublin, Ireland, and Seraing, Belgium – ERS Genomics Limited and Syngulon, a synthetic biology startup developing original genetic technologies using bacteriocins, announced today a non-exclusive license agreement which provides Syngulon with worldwide access to ERS’ CRISPR-Cas9 genome editing intellectual property for use in combination with Syngulon Patent Rights. ERS Genomics holds rights to the foundational CRISPR-Cas9 […]
Startup introduces streamlined, robust workflow for NGS sample preparation and analysis BOSTON, MA / ACCESSWIRE / Molecular Loop Biosolutions LLC, a company specializing in advanced sample preparation solutions and data analysis for next-generation DNA sequencing, is pleased to announce the acquisition of Good Start Genetics’ molecular inversion probe-based DNA targeting and analysis technology from Invitae […]
BC Platforms, a world leader in genomic data management and analytics today announced it is launching its world leading genomics platform for HUS, the Hospital District of Helsinki and Uusimaa and the largest Healthcare service provider in the whole Nordics region. BC Platforms will be providing its customizable end-to-end Software-as-a-Service platform to provide actionable reports […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
